|
EP2972365A1
|
|
Methods for treating and diagnosing systemic lupus erythematosus
|
|
US2013216530A1
|
|
Methods for optimizing biological response modifier therapy using therapeutic drug monitoring of immunosuppressants
|
|
US2013040835A1
|
|
Genes predictive of anti-TNF response in inflammatory diseases
|
|
WO2012109592A1
|
|
Methods for diagnosing systemic lupus erythematosus
|
|
WO2011127351A1
|
|
Biomarkers for ulcerative colitis and crohn's disease
|
|
US2011177531A1
|
|
Cell-Based Complement Activation Product Algorithm for Diagnosing Systemic Lupus Erythematosus
|
|
WO2009114756A2
|
|
Biomarkers for inflammatory bowel disease and irritable bowel syndrome
|
|
US2006281107A1
|
|
Acute myelogenous leukemia biomarkers
|
|
US2005287578A1
|
|
Methods for RNA fluorescence in situ hybridization
|
|
EP1756308A1
|
|
Compositions and methods for breast cancer prognosis
|
|
US2006223075A1
|
|
Unique sequence hybridization probes (USP)
|
|
US2005244872A1
|
|
Breast cancer gene expression biomarkers
|
|
US2005181389A1
|
|
Compositions for glioma classification
|
|
WO2004097050A1
|
|
Methods for in situ hybridization without the need for competitor dna
|
|
US7561971B2
|
|
Methods and devices relating to estimating classifier performance
|
